Xiangling Li
- Cardiology and Cardiovascular Medicine top 10%
- Molecular Biology
- Nephrology top 5%
- Biomedical Engineering
- Pulmonary and Respiratory Medicine
- Co-authors
- Youxia LiuJicheng LvLijun LiuWanyin HouToshiharu NinomiyaHaiyan WangVlado PerkovicHong Zhang
- Topics
- Cancer-related molecular mechanisms research (3 papers)Nerve injury and regeneration (3 papers)Mitochondrial Function and Pathology (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiangling Li
26 papers receiving 625 citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Cardiology and Cardiovascular Medicine 174
- Molecular Biology 171
- Nephrology 159
- Biomedical Engineering 111
- Pulmonary and Respiratory Medicine 106
Countries citing papers authored by Xiangling Li
This map shows the geographic impact of Xiangling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangling Li more than expected).
Fields of papers citing papers by Xiangling Li
This network shows the impact of papers produced by Xiangling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangling Li. The network helps show where Xiangling Li may publish in the future.
Co-authorship network of co-authors of Xiangling Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangling Li. A scholar is included among the top collaborators of Xiangling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangling Li. Xiangling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 0 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 64 | |
| 11 | 12 | |
| 12 | 10 | |
| 13 | 10 | |
| 14 | 1 | |
| 15 | 124 | |
| 16 | 1 | |
| 17 | 14 | |
| 18 | 1 | |
| 19 | Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trialsbreakdown → | 296 |
| 20 | 38 |
About Xiangling Li
Xiangling Li is a scholar working on Neurology, Cancer Research and Nephrology, having authored 27 papers that have together received 633 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), Nerve injury and regeneration (3 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Nephrology (159 citations), Cardiology and Cardiovascular Medicine (174 citations) and Endocrinology, Diabetes and Metabolism (85 citations). Xiangling Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Youxia Liu, Jicheng Lv, Lijun Liu, Wanyin Hou, Toshiharu Ninomiya, Haiyan Wang, Vlado Perkovic, Hong Zhang, Xinfang Xie and Na Zhao. Their work appears in journals such as Chemical Reviews, Scientific Reports and Nature Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.